Key result
The 2020 ESC guidelines for adult congenital heart disease emphasize a multidisciplinary approach and updated risk stratification, which the ACHDC-IASC supports adapting for the Latin American population.
Provides a perspective from the Interamerican Adult Congenital Heart Disease Council on the 2020 ESC guidelines for managing adults with congenital heart disease.
Highlights implementation nuances of ESC ACHD guidelines in the Americas; leaves open prospective outcome validation in regional cohorts.
Recently, the new European Society of Cardiology guidelines for the management of adult congenital heart disease were published. Due to the coronavirus pandemic, on this occasion, they were presented virtually during the last European Cardiology Congress. The greater survival of adults with congenital heart disease is a result of the latest advances in new interventionist treatments for repairing congenital heart defects, the implementation of new medical management, and, especially, better risk stratification for catheterization and surgical times.
No takes yet. Share an insight, caveat, or question.
A 2020 study conducted a review in Adult Congenital Heart Disease. 2020 ESC Guidelines for the Management of Adult Congenital Heart Disease was evaluated. The 2020 ESC guidelines for adult congenital heart disease emphasize a multidisciplinary approach and updated risk stratification, which the ACHDC-IASC supports adapting for the Latin American population.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: